It is suggested that LGLL cases with STAT5B mutations possess a more aggressive course, different from typical LGLL with a relatively favorable prognosis.[16] Our case with STAT5B mutation manifested as an aggressive variant with poor outcome, indicating aberrant STAT5B signaling underlies the pathogenesis of this rare disease. This evidence concerns the gene STAT5B and T-cell large granular lymphocyte leukemia.